Compare · CERS vs WDAY
CERS vs WDAY
Side-by-side comparison of Cerus Corporation (CERS) and Workday Inc. (WDAY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CERS and WDAY operate in EDP Services (Technology), so they compete in similar markets.
- WDAY is the larger of the two at $59.55B, about 68.7x CERS ($866.5M).
- Over the past year, CERS is up 47.8% and WDAY is down 50.1% - CERS leads by 97.9 points.
- WDAY has been more active in the news (16 items in the past 4 weeks vs 4 for CERS).
- WDAY has more recent analyst coverage (25 ratings vs 3 for CERS).
- Company
- Cerus Corporation
- Workday Inc.
- Price
- -
- -
- Market cap
- $866.5M
- $59.55B
- 1M return
- +7.03%
- -5.76%
- 1Y return
- +47.76%
- -50.12%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1997
- News (4w)
- 4
- 16
- Recent ratings
- 3
- 25
Cerus Corporation
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.
Workday Inc.
Workday, Inc. provides enterprise cloud applications worldwide. Its applications help its customers to manage critical business functions and optimize their financial and human resources. The company offers a suite of financial management applications, which enable chief financial officers to maintain accounting information in the general ledger; manage financial processes; identify real-time financial, operational, and management insights; enhance financial consolidation; reduce time-to-close; promote internal control and auditability; and achieve consistency across finance operations. It also provides cloud spend management solutions; a suite of human capital management applications that allows organizations to manage the entire employee lifecycle from recruitment to retirement; Workday applications for planning; and applications for analytics and reporting, including augmented analytics to surface insights to the line of business in simple-to-understand stories, machine learning to drive efficiency and automation, and benchmarks to compare performance against other companies. In addition, the company offers Workday applications serving industries, such as healthcare, higher education, and professional services. It serves technology, financial services, business and professional services, healthcare and life sciences, manufacturing, retail, and hospitality industries; and educational institutions, government agencies, and nonprofit organizations. Workday, Inc. has a strategic partnership with Google LLC to digitally transform enterprises worldwide. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was founded in 2005 and is headquartered in Pleasanton, California.
Latest CERS
- SEC Form DEFA14A filed by Cerus Corporation
- SEC Form DEF 14A filed by Cerus Corporation
- Cerus Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
- SEC Form 4 filed by Green Kevin Dennis
- SEC Form 4 filed by Jensen Chrystal
- Amendment: SEC Form SCHEDULE 13G/A filed by Cerus Corporation
- Chief Legal Officer Jensen Chrystal sold $187,277 worth of shares (113,008 units at $1.66), decreasing direct ownership by 11% to 946,131 units (SEC Form 4)
- Chief Operating Officer Jayaraman Vivek K sold $273,769 worth of shares (165,200 units at $1.66), decreasing direct ownership by 9% to 1,747,674 units (SEC Form 4)
- President and CEO Greenman William Mariner sold $742,023 worth of shares (447,757 units at $1.66), decreasing direct ownership by 8% to 4,998,493 units (SEC Form 4)
Latest WDAY
- Workday Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- EZE Cloud Consulting Advances AI-first Strategy with Agile In-house Deployment of Workday GO
- Workday and Achievers Launch AI‑Powered Recognition and Rewards Solution to Boost Employee Engagement and Retention
- SEC Form 4 filed by Garfield Mark S.
- Outdated Technology Increases Risk and Impedes Mission Readiness for Federal Finance Teams, Workday Government Research Shows
- SEC Form 4 filed by Duffield David A
- SEC Form 144 filed by Workday Inc.
- SEC Form 4 filed by Kazmaier Gerrit S
- SEC Form 4 filed by Garfield Mark S.
- SEC Form 4 filed by Bhusri Aneel